Medlab Clinical Ltd (ASX: MDC) Share Price and News

Price

$6.60

Movement

( )

As at 3 Mar - Closed (20 mins delayed)

52 Week Range

-

 
1 Year Return

0.0

Medlab Clinical Ltd Chart and Price Data

2025
2025
2025
2025

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $15.07 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 2.28 million
Earnings per share -0.930
Dividend per share N/A
Year To Date Return N/A
Earnings Yield N/A
Franking -
Earnings Yield

N/A

Franking

-

Dividend per share

N/A

Year To Date Return

N/A

Shares Outstanding

2.28 million

Earnings per share

-0.930

Share Price

$6.60

Day Change

( )

52 Week Range

-

Yesterday's Close

$6.60

Today's Open

Days Range

-

Volume

0

Avg. Volume (1 month)

0

Turnover

$0

As at 3 Mar - Closed

  • Medlab Clinical Ltd (ASX: MDC)
    Latest News

    Medical staff wear hero capes, indicting strong shar [price performace for healthcare shares
    Healthcare Shares

    Why is the Medlab (ASX:MDC) share price surging 8% today?

    The Medlab (ASX: MDC) share price is rising today after the European Patent Office announced its intention to grant Nanocelle…

    Read more »

    high share price
    Share Market News

    Here's why the Medlab (ASX:MDC) share price is rising today

    The Medlab Clinical Ltd (ASX: MDC) share price is treading upwards today after announcing an agreement Arrotex. Here's what you…

    Read more »

    a woman
    Share Gainers

    Why Clean TeQ, Medlab, Newcrest, & Ramelius are storming higher today

    Medlab Clinical Ltd (ASX:MDC) and Newcrest Mining Limited (ASX:NCM) shares are storming higher on Monday. Here's why...

    Read more »

    a woman
    Share Gainers

    Why this ASX cannabis share is shooting 15% higher today

    The Medlab Clinical Ltd (ASX:MDC) share price is shooting higher on Monday despite the market selloff. Here's why this cannabis…

    Read more »

    a woman
    Share Gainers

    Why THC Global and these ASX cannabis shares are rocketing higher today

    The THC Global Group Ltd (ASX:THC) share price and these cannabis shares are rocketing higher on Monday. Here's why...

    Read more »

    a woman
    52-Week Highs

    Why this ASX biotech is printing 52-week highs

    The Medlab Clinical Ltd (ASX: MDC) share price is rising after the company announced it has signed a Heads of Agreement…

    Read more »

    a woman
    Share Gainers

    This small-cap ASX biotech's share price is soaring today

    An operations update for the June quarter sees the Medlab Clinical Ltd (ASX: MDC) share price soar in Thursday trade.

    Read more »

    a woman
    Share Gainers

    Why Medlab, Metcash, SKY and Space Global, and WiseTech shares charged higher today

    The Metcash Limited (ASX:MTS) share price and the WiseTech Global Ltd (ASX:WTC) share price are two of four charging higher…

    Read more »

    a woman
    Share Market News

    These small cap ASX shares are on the rise today

    The Slater & Gordon Limited (ASX:SGH) share price is one of three in the small cap space climbing higher on…

    Read more »

    a woman
    Investing

    Is Medlab Clinical Ltd the best small cap healthcare buy on the ASX?

    brokers are circling biological research company Medlab Clinical Ltd (ASX: MDC) as a potential buy

    Read more »

    a woman
    Investing

    Why these pot stocks are moving higher

    Pot stocks continue to provide investors with strong returns…

    Read more »

    a woman
    Investing

    Why shares of Medlab Clinical Ltd have risen 37% in 2018

    Shares of Medlab Clinical Ltd (ASX:MDC) have had an excellent start to 2018 with the company's share price rising 37% to…

    Read more »

    MDC ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    28th Feb 2025 2025-02-28T09:20:07 Removal from Official ListYesNo9:20am1547k
    14th Feb 2025 2025-02-14T09:16:05 Results of Meeting 2024YesNo9:16am296k
    14th Feb 2025 2025-02-14T09:15:40 Results of Meeting 2023YesNo9:15am297k
    3rd Feb 2025 2025-02-03T14:08:11 Quarterly Activities/Appendix 4C Cash Flow ReportYesNo2:08pm6353k
    22nd Jan 2025 2025-01-22T16:20:01 Long Term Suspended EntitiesYesNo4:20pm8206k
    10th Jan 2025 2025-01-10T16:08:40 Notice of Annual General Meeting/Proxy FormYesNo4:08pm13408k
    10th Jan 2025 2025-01-10T16:08:00 Notice of General Meeting/Proxy FormYesNo4:08pm15423k
    13th Dec 2024 2024-12-13T09:54:23 Response to Appendices 3X and 3Z QueryYesNo9:54am3812k
    4th Dec 2024 2024-12-04T14:59:09 Final Director's Interest NoticeYesNo2:59pm2162k
    4th Dec 2024 2024-12-04T14:58:34 Initial Director's Interest NoticeYesNo2:58pm2200k

    About Medlab Clinical Ltd

    Medlab Clinical Ltd. engages in the development of therapeutic pathways for diagnosed chronic diseases. It operates through the Nutraceutical Sales and Pharmaceutical Research segments. Its products include BifidoBiotic, BioClean, Biotic Jnr., GastroDaily, Lactoferrin Enhanced, Manuka-C, NanoCelle, NeuroActiv, NRGBiotic, and ORSBiotic. The company was founded by Sean Hall on June, 2012 and is headquartered in Botany, Australia.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Sean Michael Hall Chief Executive Officer Apr 2014
    Mr Hall has over 20 years of experience in the Australian Healthcare and food industries and early phase drug discovery in Australia and Asia. Sean is best known for building Australia's practitioner brand, BioCeuticals. Dr Hall is a member of Medicines Australia, American Federation for Medical Research, American Academy of Anti-Ageing Medicine, Ausbiotech, a member of the Scientific Advisory Board for BITs Life Science China and a Board Member of the International Probiotics Association.
    Mr Tim Walker Non-Executive Director Mar 2024
    Mr Walker is a corporate finance professional with experience in originating, managing, and leading resource-focused transaction. Specialising in M&A transactions across the Canadian and Australian markets, IPOs, and equity and debt financing solutions. Tim's past directorships with exploration companies have provided him with experience across commodity groups, including lithium exploration, rare earth and niobium hosted carbonatite deposits, whilst also having experience transacting on iron ore and base metal projects.
    Mr Edmond Tan Non-Executive Director Mar 2024
    Mr Tan is a financial services professional with over 10 years' experience in roles which include Private Wealth Management, Family Office, and Structured Finance. In addition, he was involved in the establishment of a mid-market private equity joint venture fund with a focus on foreign investment into Australia. Currently, Mr Tan is a Director of Regenerate Pty Ltd a rare earth magnet recycling technology based in Houston, Texas. He is also the Australian Representative for Obsidian Global Partners LLC, a structured financier for ASX listed companies.
    Mr Joshua David Light Non-Executive Director Nov 2024
    Mr Light is a corporate finance with broad expertise in investment banking and corporate advisory, particularly within the mining and resources sector. He has managed and facilitated numerous M&A transactions and capital raisings across primary and secondary markets in Australia and North America. Josh brings a understanding of base and critical metals and has coordinated various resource acquisitions at the junior market level.
    Mr Kerem Kaya Chief Financial OfficerCompany Secretary May 2021
    -
    Kerem Kaya Chief Financial OfficerCompany Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Mr Sean Michael Hall 389,041 17.04%
    Farjoy Pty Ltd 205,663 9.01%
    HSBC Custody Nominees (Australia) Limited 88,229 3.86%
    UBS Nominees Pty Ltd 85,316 3.74%
    Fit Investments Pty Ltd Hallab Investment A/C 75,563 3.31%
    Realm Group Pty Limited 54,705 2.40%
    Citicorp Nominees Pty Limited 49,798 2.18%
    Mr Drew Anthony Townsend Townsend Family A/C 37,038 1.62%
    Richard Albarran Albarran Family No 2 A/C 37,038 1.62%
    United Trolley Collections P/L 32,970 1.44%
    BNP Paribas Nominees Pty Ltd Ib Au Noms Retailclient 30,272 1.33%
    Mr Michael Jack Hall & Mrs Elizabeth Ann Jones Hall Jones Super Fund A/C 29,820 1.31%
    Netwealth Investments Limited Wrap Services A/C 20,186 0.88%
    Villamagna Inc 20,000 0.88%
    BNP Paribas Noms Pty Ltd 17,164 0.75%
    Daniel P Moses (Nominees) Pty Limited Daniel Moses Family A/C 16,667 0.73%
    Acron Holdings Pty Limited Acron Super Fund A/C 16,181 0.71%
    Kenney Family Investments Pty Ltd Kenney Family Account 15,295 0.67%
    Assumo (Nominees) Pty Ltd Assumo S/Fund A/C 13,334 0.58%
    D J Fairfull Pty Ltd Fairfull Super Fund A/C 12,651 0.55%

    Profile

    since

    Note